Home/Investors/National Institute on Drug Abuse (NIDA)

National Institute on Drug Abuse (NIDA)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$1.9M
Focus Areas
5
Top Stage
Phase 2

Portfolio Companies

CompanyValuation
Ensysce Biosciences$1.9M
Advanced Brain Monitoring